Requiring certain cost-sharing assistance be applied toward a covered individual's deductible or annual out-of-pocket limit under the individual's health benefit plan.
Died in Committee
Summary
The bill would make any amount paid for a prescription drug—by the patient or a third party—count toward the individual’s deductible or annual out‑of‑pocket maximum when the drug has no generic or biosimilar equivalent, or when a brand‑name drug is used after prior authorization or step‑therapy. It applies to health insurers, pharmacy benefit managers and pharmacy‑administrative service organizations, affecting Kansas residents with health plans. The goal is to reduce the amount patients must pay before insurance coverage begins.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 423 changes status, plus AI-powered summaries and stage predictions.
Sign up free